The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 17, 2023

Filed:

Jul. 25, 2018
Applicant:

Innoblative Designs, Inc., Chicago, IL (US);

Inventors:

Robert F. Rioux, Ashland, MA (US);

Alyssa Bailey, Chicago, IL (US);

Tyler Wanke, Chicago, IL (US);

Ryan M. Bean, Westminster, MA (US);

Assignee:

Innoblative Designs, Inc., Chicago, IL (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 18/14 (2006.01); A61B 90/00 (2016.01); A61B 18/12 (2006.01); A61B 18/00 (2006.01);
U.S. Cl.
CPC ...
A61B 18/1492 (2013.01); A61B 18/1206 (2013.01); A61B 90/37 (2016.02); A61B 2018/00255 (2013.01); A61B 2018/00541 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/00791 (2013.01); A61B 2018/00875 (2013.01); A61B 2018/126 (2013.01); A61B 2090/378 (2016.02); A61B 2090/3762 (2016.02); A61B 2218/002 (2013.01);
Abstract

The present invention is a minimally invasive articulating configured to be advanced through tortuous anatomy, particularly within a lung, and subsequently deliver at least two separately deployable ablation devices to a target site located at a bifurcated section of the lung (i.e., at a bronchial airway bifurcation). The pair of ablation devices are separately steerable towards respective first and second pathways extending from the bifurcation, such that each of the ablation devices can be positioned on either side of a target tissue proximate the bifurcation. The first and second ablation devices include expandable distal tips configured to transition to a deployed configuration, in which each expands in diameter and is configured to apply a degree of compression and/or RF energy emission to target lung tissue (i.e., diseased tissue, such as cancer or emphysema-related damaged tissue) for subsequent ablation thereof.


Find Patent Forward Citations

Loading…